Mesoporous silica nanoparticles for pulmonary drug delivery

A Garcia-Fernandez, F Sancenon… - Advanced Drug Delivery …, 2021 - Elsevier
Over the last years, respiratory diseases represent a clinical concern, being included among
the leading causes of death in the world due to the lack of effective lung therapies, mainly …

Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities

S Mangal, W Gao, T Li, QT Zhou - Acta pharmacologica sinica, 2017 - nature.com
Lung cancer is the second most prevalent and the deadliest among all cancer types.
Chemotherapy is recommended for lung cancers to control tumor growth and to prolong …

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines

GA Silvestri, MK Gould, ML Margolis, LT Tanoue… - Chest, 2007 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
the prognosis differ significantly by stage. Several noninvasive imaging studies including …

Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer

K Yasufuku, T Nakajima, K Motoori, Y Sekine… - Chest, 2006 - Elsevier
Study objectives To perform a prospective comparison of direct real-time endobronchial
ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA), positron emission …

Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer

K Yasufuku, M Chiyo, E Koh, Y Moriya, A Iyoda… - Lung cancer, 2005 - Elsevier
During the staging process of lung cancer, accurate mediastinal lymph node staging is one
of the important factors which affect patient management. The purpose of the current study …

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of non-small cell lung cancer via integrated bioinformatics analysis

M Ni, X Liu, J Wu, D Zhang, J Tian, T Wang, S Liu… - Frontiers in …, 2018 - frontiersin.org
Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80–85% of all
patients with lung cancer and 5-year relative overall survival (OS) rate is less than 20%, so …

Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis

JEC Holty, WG Kuschner, MK Gould - Thorax, 2005 - thorax.bmj.com
Background: The reported accuracy of transbronchial needle aspiration (TBNA) for
mediastinal staging in non-small cell lung cancer (NSCLC) varies widely. We performed a …

Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions

G Paone, E Nicastri, G Lucantoni, RD Iacono… - Chest, 2005 - Elsevier
Study objectives: The aim of our study was to compare the diagnostic yield of two
bronchoscopic procedures: endobronchial ultrasound-driven transbronchial biopsy (EBUS …

Limited resection for the treatment of patients with stage IA lung cancer

JP Wisnivesky, CI Henschke, S Swanson… - Annals of …, 2010 - journals.lww.com
Objective: Lobectomy is the standard of care for stage IA lung cancer. Some small
retrospective studies have suggested similar results after limited resection for tumors≤ 2 cm …

Treatment and survival disparities in lung cancer: the effect of social environment and place of residence

AM Johnson, RB Hines, JA Johnson III, AR Bayakly - Lung Cancer, 2014 - Elsevier
Objective The purpose of this study was to measure the extent to which geographic
residency status and the social environment are associated with disease stage at diagnosis …